The effect of hypercholesterolemia on carbachol-induced contractions of the detrusor smooth muscle in rats: increased role of L-type Ca2+ channels

Naunyn Schmiedebergs Arch Pharmacol. 2012 Nov;385(11):1141-8. doi: 10.1007/s00210-012-0784-5. Epub 2012 Aug 7.

Abstract

To investigate a possible relation between hypercholesterolemia and detrusor smooth muscle function, we studied the contractile response to potassium challenge, carbachol (CCh), and the components of CCh-induced contractile mechanism in high-cholesterol diet-fed rats. Adult male Sprague-Dawley rats were fed with standard (control group, N = 17) or 4 % cholesterol diet (hypercholesterolemia group (HC), N = 16) for 4 weeks. Spontaneous contractions of detrusor muscle strips and their responses to potassium chloride (KCl) or cumulative dose-contraction curves to CCh were recorded. The effects of muscarinic receptor antagonists (methoctramin and/or 4-diphenylacetoxy-N-methylpiperidine), L-type Ca(+2) channel blocker (nifedipine), and/or rho-kinase inhibitor Y-27632 were investigated. Blood cholesterol level was increased in the HC group with no sign of atherosclerosis. The KCl-induced detrusor smooth muscle contractions were higher in HC, whereas spontaneous and CCh-induced responses were similar in both groups. Preincubation with receptor antagonist for M(3) but not for M(2) attenuated contraction significantly, shifting the dose-response curve to the right. This response was similar in both groups. Among two effector mechanisms of M(3)-mediated detrusor smooth muscle contraction, rho-kinase pathway was not affected by hypercholesterolemia, whereas blockade of L-type Ca(+2) channels potently reduced contractions. The results of this study point out a relation between hypercholesterolemia and contractile mechanism of detrusor smooth muscle likely to change urinary bladder function, via altering L-type Ca(+2) channels. Taken together with escalating incidence of hypercholesterolemia and lower urinary tract symptoms, it is a field which deserves to be investigated further.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Animals
  • Calcium Channels, L-Type / metabolism*
  • Carbachol / administration & dosage
  • Carbachol / pharmacology*
  • Cholinergic Agonists / administration & dosage
  • Cholinergic Agonists / pharmacology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Hypercholesterolemia / physiopathology*
  • Male
  • Muscarinic Antagonists / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Nifedipine / pharmacology
  • Potassium Chloride / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / metabolism
  • Urinary Bladder / drug effects*
  • Urinary Bladder / metabolism

Substances

  • Amides
  • Calcium Channels, L-Type
  • Cholinergic Agonists
  • Muscarinic Antagonists
  • Pyridines
  • Receptors, Muscarinic
  • Y 27632
  • Potassium Chloride
  • Carbachol
  • Nifedipine